Profound Medical (PROF) Shares Outstanding (2018 - 2026)

Profound Medical has reported Shares Outstanding (Entity) for 9 years, with the latest figure at $36.5 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 21.56% year-over-year to $36.5 million in Q2 2026; TTM through Jun 2026 was $36.5 million, a 21.56% increase from a year earlier, with the FY2025 full-year figure at $30.2 million, up 22.08% from the prior year.
• Shares Outstanding (Entity) was $36.5 million for Q2 2026 at Profound Medical, up from $36.3 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $36.5 million in Q2 2026, with the low at $20.9 million in Q4 2022.
• Average Shares Outstanding (Entity) over 5 years is $27.8 million, with a median of $27.4 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) grew 0.5% in 2022, then grew 23.7% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $20.9 million in 2022, then gained by 2.35% to $21.4 million in 2023, then gained by 15.89% to $24.8 million in 2024, then increased by 22.08% to $30.2 million in 2025, then grew by 20.84% to $36.5 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $36.5 million (Q2 2026), $36.3 million (Q1 2026), and $30.2 million (Q4 2025), per Business Quant data.